MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

A Virtual Speech Therapist for Parkinson’s Disease

A. Halpern, L. Ramig, R. Cole (Denver, CO, USA)

Meeting: MDS Virtual Congress 2020

Abstract Number: 1199

Keywords: Dysarthria, Parkinsonism, Rehabilitation

Category: Physical Therapy, Speech Therapy, Rehabilitation

Objective: This study was designed as a pilot investigation to explore the use of virtual therapy in the delivery of LSVT LOUD ® (Lee Silverman Voice Treatment).

Background: Nearly 90% of individuals with PD have a speech or voice disorder which historically has been resistant to medical or behavioral treatment. Today LSVT LOUD is the only speech treatment with published data from three randomized control trials (RCTs) documenting short and long term improvement in speech and voice in PD (1). The need for accessibility to efficacious speech treatment continues to grow and is being addressed in part through telepractice (2) and software-supported delivery systems (3). The work proposed here presents a novel idea for conducting LSVT LOUD using a fully automated computer program in which a perceptive, lifelike, animated 3D computer character (LSVT-VT) interacts with individuals with PD much like a human therapist. This pilot study blends an efficacious treatment (LSVT LOUD) with cutting edge human communication and animation technologies (4).

Method: Subjects: 14 individuals participated, 7 with mild to moderate PD and 7 significant others (SOs).
Treatment: The LSVT-VT was used for 9-12 of the standard 16 LSVT LOUD sessions.
Experimental data collection and analysis: Pre and post speech and voice data including sound pressure level (SPL) were collected while Ss performed a range of tasks. Ss with PD also completed perceptual rating scales and a questionnaire regarding their experience with the LSVT-VT. SOs completed rating scales to report their perception of the speech of the Ss pre to post treatment.

Results: Pre to post SPL increases ranged from 5.3-13.3dB at 30cm across a range of tasks. These changes are comparable to standard LSVT LOUD treatment outcomes (1). Perceptual ratings by both the Ss with PD and SO were consistent with these data. The majority of the individuals with PD rated the LSVT-VT easy to use, engaging and helpful with speech.

Conclusion: This pilot study is a step in incorporating virtual therapy technology in voice treatment for PD. Clinical experience suggests individuals who have cognitive challenges, substantial sensory calibration issues or have more severely disordered voices, may need more direct clinician time. Future research will help determine which individuals will be most appropriate for the LSVT-VT.
Support: NIH-NIDCD R01 DC01150; R21 DC006078

References: (1) Ramig, L., Halpern, A., Spielman, J., Fox, C. and Freeman, K. (2018). Speech Treatment in Parkinson’s Disease: Randomized Controlled Trial (RCT). Movement Disorders, 33:1777-1791. (2) Halpern, A., Ramig, L., Matos, C., Petska-Cable, J., Spielman, J., Pogoda, J., Gilley, P., Sapir, S., Bennett, J., & McFarland, D. (2012). Innovative technology for the assisted delivery of intensive voice treatment (LSVT®LOUD) for Parkinson disease. American Journal of Speech-Language Pathology, 21: 354-367. This article was awarded the 2012 Editors’ Award for the American Journal of Speech-Language Pathology. (3) Theodoros, D., Hill, A., Russell, T. (2016) Clinical quality of life outcomes and speech treatment for Parkinson’s disease delivered to the home via telerehabilitaion: a non inferiority randomized controlled trial. American Journal of Speech-Language Pathology, 25: 214-232. (4) Cole, R., Halpern, A., Ramig, L., van Vuuren, S., Ngampatipatpong, N., & Yan, J. (2006). A virtual speech therapist for individuals with Parkinson disease. Educational Technology, 47: 51-55.

To cite this abstract in AMA style:

A. Halpern, L. Ramig, R. Cole. A Virtual Speech Therapist for Parkinson’s Disease [abstract]. Mov Disord. 2020; 35 (suppl 1). https://www.mdsabstracts.org/abstract/a-virtual-speech-therapist-for-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2020

MDS Abstracts - https://www.mdsabstracts.org/abstract/a-virtual-speech-therapist-for-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley